Levofloxacin Tablet, Film Coated
Product Images NDC 71205-002

6 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 71205-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levofloxacinfigure2a (64141d0d 0347 470f A427 9925a2eb357e 00)

Levofloxacinfigure2a (64141d0d 0347 470f A427 9925a2eb357e 00)
A line graph depicting plasma concentration (ng/mL) over time (hours). It compares the plasma concentration of 750 mg Levofloxacin administered orally as a tablet and intravenously as a 90-minute infusion, showing a decline in concentration over a 36-hour period.*
FDA Label Image

Camber Logo (Image 01)

FDA Label Image

71205-002-07 (Image 02)

71205-002-07 (Image 02)
Label for Levofloxacin 500 mg film coated tablets by Proficient Rx LP. The label indicates the tablets are oral, orange-colored, capsule-shaped, biconvex, and debossed with '2b' and '1'. Includes storage instructions (20°-25°C) and product ID QL000207. Manufacturer is Hetero Labs Limited, India. NDC 71205-002.*
FDA Label Image

Levofloxacinaddress2 (Image 03)

FDA Label Image

Levofloxacinfigure1 (Levofloxacinfigure1)

Levofloxacinfigure1 (Levofloxacinfigure1)
Chemical structure of Levofloxacin, a fluoroquinolone antibiotic. The diagram shows the molecular arrangement, including a fluorine atom and various ring structures, with a notation indicating a half molecule of water (1/2 H2O) as part of the compound.*
FDA Label Image

Levofloxacinfigure3 (Levofloxacinfigure3)

Levofloxacinfigure3 (Levofloxacinfigure3)
A line graph depicting plasma concentration (mg/mL) over time (hours) comparing 500 mg Levofloxacin administered orally (tablet) versus intravenously (i.v.). The graph shows concentration trends from 0 to 36 hours post-dosing for both administration routes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.